Is Sputnik V the most reliable vaccine out there?

The ever-lasting wait for a vaccine is now finally over as different vaccines have stormed the market and have created a dilemma for a typical vaccine-seeker. Sputnik V has proved to be one of the most prominent of them all. Here's how:

Sputnik V is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It was spotted first on 11 August 2020, listed by the Russian Ministry of Health.

On Twenty-Four June, it was declared the safest COVID vaccine by the Buenos Aires Ministry of Health.

An astonishing fact to notice is that no deaths resulted from the vaccination in the Buenos Aires province in Argentina. Also, most post-vaccination events were seemingly mild.

The domain of this survey conducted was to demonstrate the occurrence of Events Supposedly Attributable to Vaccination or Immunization (ESAVI) to the Integrated Argentine Health Information System (SIISA) after the people of Buenos Aires were vaccinated on 29 December 2020; campaign start day was 3 June 2021.

During that timeline, 2.8 million doses of the "Sputnik V"; 1.3 million from Sinopharm, and 0.9 million of Covishield/AstraZeneca were applied with a severe ESAVI rate (product-related) per million doses of 0.7, 0.8, and 3.2 respectively, as stated by the research.

The research verified that the reported ESAVI had no severe consequences. The commonly reported side effects were fever (47%), headaches (45%), muscle pain and joint pain (39.5%) and pain (46.5%), and swelling (7.4%) at the site of application.

Each reported ESAVI had passed through a classification process based on a sequence of categories established by WHO (World Health Organization) and the PAHO (Pan American Health Organization).

Moreover, WHO did not raise a single question regarding the safety and efficacy of the manufactured and finished vaccine as the "Sputnik V" vaccine undergoes the severest quality assurance control by the Gamaleya Institute and the Russian health regulator (Federal Healthcare Service – Rosdravnadzor), as stated by the OJSC Pharmstandard-UfaVITA.

Well, despite all these efforts, the dilemma still follows as to whether the vaccines which rolled out six months ago will be effective against the new Delta Variant or not. On the positive side of things, these vaccines have laid a foundation for the emergence of better ones. Sputnik V is one of the fine examples of excellence in the vaccine catalogue. Still, the world thrives for a once and for all solution to the ongoing pandemic.

---